Eintrag weiter verarbeiten
Occurrence of Antithrombotic Related Adverse Events in Hospitalized Patients: Incidence and Clinical Context between 2008 and 2016
Gespeichert in:
| Zeitschriftentitel: | Journal of Clinical Medicine |
|---|---|
| Personen und Körperschaften: | , , , , , , , |
| In: | Journal of Clinical Medicine, 8, 2019, 6, S. 839 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
MDPI AG
|
| Schlagwörter: |
| author_facet |
Moesker, Marco J. Schutijser, Bernadette C.F.M. de Groot, Janke F. Langelaan, Maaike Spreeuwenberg, Peter Huisman, Menno V. de Bruijne, Martine C. Wagner, Cordula Moesker, Marco J. Schutijser, Bernadette C.F.M. de Groot, Janke F. Langelaan, Maaike Spreeuwenberg, Peter Huisman, Menno V. de Bruijne, Martine C. Wagner, Cordula |
|---|---|
| author |
Moesker, Marco J. Schutijser, Bernadette C.F.M. de Groot, Janke F. Langelaan, Maaike Spreeuwenberg, Peter Huisman, Menno V. de Bruijne, Martine C. Wagner, Cordula |
| spellingShingle |
Moesker, Marco J. Schutijser, Bernadette C.F.M. de Groot, Janke F. Langelaan, Maaike Spreeuwenberg, Peter Huisman, Menno V. de Bruijne, Martine C. Wagner, Cordula Journal of Clinical Medicine Occurrence of Antithrombotic Related Adverse Events in Hospitalized Patients: Incidence and Clinical Context between 2008 and 2016 General Medicine |
| author_sort |
moesker, marco j. |
| spelling |
Moesker, Marco J. Schutijser, Bernadette C.F.M. de Groot, Janke F. Langelaan, Maaike Spreeuwenberg, Peter Huisman, Menno V. de Bruijne, Martine C. Wagner, Cordula 2077-0383 MDPI AG General Medicine http://dx.doi.org/10.3390/jcm8060839 <jats:p>Antithrombotic drugs are consistently involved in medication-related adverse events (MRAEs) in hospitalized patients. We aimed to estimate the antithrombotic-related adverse event (ARAE) incidence between 2008 and 2016 and analyse their clinical context in hospitalized patients in The Netherlands. A post-hoc analysis of three national studies, aimed at adverse event (AE) identification, was performed. Previously identified AEs were screened for antithrombotic involvement. Crude and multi-level, case-mix adjusted ARAE and MRAE incidences were calculated. Various contextual ARAE characteristics were analysed. ARAE incidence between 2008 and 2016 decreased significantly in in-hospital deceased patients from 1.20% (95% confidence interval (CI): 0.63–2.27%) in 2008 to 0.54% (95% CI: 0.27–1.11%) in 2015/2016 (p = 0.02). In discharged patients ARAE incidence remained stable. By comparison, overall MRAE incidence remained stable for both deceased and discharged patients. Most ARAEs involved Vitamin-K antagonists (VKAs). Preventable ARAEs occurred more during weekends and with increasing multidisciplinary involvement. Antiplatelet and combined antithrombotic use seemed to be increasingly involved in ARAEs over time. ARAE incidence declined by 55% in deceased patients between 2008 and 2016. Opportunities for improving antithrombotic safety should target INR monitoring and care delivery aspects such as multidisciplinary involvement and weekend care. Future ARAE monitoring for the involvement of antiplatelet, combined antithrombotic and direct oral anticoagulant (DOAC) use is recommended.</jats:p> Occurrence of Antithrombotic Related Adverse Events in Hospitalized Patients: Incidence and Clinical Context between 2008 and 2016 Journal of Clinical Medicine |
| doi_str_mv |
10.3390/jcm8060839 |
| facet_avail |
Online Free |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzM5MC9qY204MDYwODM5 |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzM5MC9qY204MDYwODM5 |
| institution |
DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 |
| imprint |
MDPI AG, 2019 |
| imprint_str_mv |
MDPI AG, 2019 |
| issn |
2077-0383 |
| issn_str_mv |
2077-0383 |
| language |
English |
| mega_collection |
MDPI AG (CrossRef) |
| match_str |
moesker2019occurrenceofantithromboticrelatedadverseeventsinhospitalizedpatientsincidenceandclinicalcontextbetween2008and2016 |
| publishDateSort |
2019 |
| publisher |
MDPI AG |
| recordtype |
ai |
| record_format |
ai |
| series |
Journal of Clinical Medicine |
| source_id |
49 |
| title |
Occurrence of Antithrombotic Related Adverse Events in Hospitalized Patients: Incidence and Clinical Context between 2008 and 2016 |
| title_unstemmed |
Occurrence of Antithrombotic Related Adverse Events in Hospitalized Patients: Incidence and Clinical Context between 2008 and 2016 |
| title_full |
Occurrence of Antithrombotic Related Adverse Events in Hospitalized Patients: Incidence and Clinical Context between 2008 and 2016 |
| title_fullStr |
Occurrence of Antithrombotic Related Adverse Events in Hospitalized Patients: Incidence and Clinical Context between 2008 and 2016 |
| title_full_unstemmed |
Occurrence of Antithrombotic Related Adverse Events in Hospitalized Patients: Incidence and Clinical Context between 2008 and 2016 |
| title_short |
Occurrence of Antithrombotic Related Adverse Events in Hospitalized Patients: Incidence and Clinical Context between 2008 and 2016 |
| title_sort |
occurrence of antithrombotic related adverse events in hospitalized patients: incidence and clinical context between 2008 and 2016 |
| topic |
General Medicine |
| url |
http://dx.doi.org/10.3390/jcm8060839 |
| publishDate |
2019 |
| physical |
839 |
| description |
<jats:p>Antithrombotic drugs are consistently involved in medication-related adverse events (MRAEs) in hospitalized patients. We aimed to estimate the antithrombotic-related adverse event (ARAE) incidence between 2008 and 2016 and analyse their clinical context in hospitalized patients in The Netherlands. A post-hoc analysis of three national studies, aimed at adverse event (AE) identification, was performed. Previously identified AEs were screened for antithrombotic involvement. Crude and multi-level, case-mix adjusted ARAE and MRAE incidences were calculated. Various contextual ARAE characteristics were analysed. ARAE incidence between 2008 and 2016 decreased significantly in in-hospital deceased patients from 1.20% (95% confidence interval (CI): 0.63–2.27%) in 2008 to 0.54% (95% CI: 0.27–1.11%) in 2015/2016 (p = 0.02). In discharged patients ARAE incidence remained stable. By comparison, overall MRAE incidence remained stable for both deceased and discharged patients. Most ARAEs involved Vitamin-K antagonists (VKAs). Preventable ARAEs occurred more during weekends and with increasing multidisciplinary involvement. Antiplatelet and combined antithrombotic use seemed to be increasingly involved in ARAEs over time. ARAE incidence declined by 55% in deceased patients between 2008 and 2016. Opportunities for improving antithrombotic safety should target INR monitoring and care delivery aspects such as multidisciplinary involvement and weekend care. Future ARAE monitoring for the involvement of antiplatelet, combined antithrombotic and direct oral anticoagulant (DOAC) use is recommended.</jats:p> |
| container_issue |
6 |
| container_start_page |
0 |
| container_title |
Journal of Clinical Medicine |
| container_volume |
8 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792334819817947138 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T14:34:43.616Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Occurrence+of+Antithrombotic+Related+Adverse+Events+in+Hospitalized+Patients%3A+Incidence+and+Clinical+Context+between+2008+and+2016&rft.date=2019-06-12&genre=article&issn=2077-0383&volume=8&issue=6&pages=839&jtitle=Journal+of+Clinical+Medicine&atitle=Occurrence+of+Antithrombotic+Related+Adverse+Events+in+Hospitalized+Patients%3A+Incidence+and+Clinical+Context+between+2008+and+2016&aulast=Wagner&aufirst=Cordula&rft_id=info%3Adoi%2F10.3390%2Fjcm8060839&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792334819817947138 |
| author | Moesker, Marco J., Schutijser, Bernadette C.F.M., de Groot, Janke F., Langelaan, Maaike, Spreeuwenberg, Peter, Huisman, Menno V., de Bruijne, Martine C., Wagner, Cordula |
| author_facet | Moesker, Marco J., Schutijser, Bernadette C.F.M., de Groot, Janke F., Langelaan, Maaike, Spreeuwenberg, Peter, Huisman, Menno V., de Bruijne, Martine C., Wagner, Cordula, Moesker, Marco J., Schutijser, Bernadette C.F.M., de Groot, Janke F., Langelaan, Maaike, Spreeuwenberg, Peter, Huisman, Menno V., de Bruijne, Martine C., Wagner, Cordula |
| author_sort | moesker, marco j. |
| container_issue | 6 |
| container_start_page | 0 |
| container_title | Journal of Clinical Medicine |
| container_volume | 8 |
| description | <jats:p>Antithrombotic drugs are consistently involved in medication-related adverse events (MRAEs) in hospitalized patients. We aimed to estimate the antithrombotic-related adverse event (ARAE) incidence between 2008 and 2016 and analyse their clinical context in hospitalized patients in The Netherlands. A post-hoc analysis of three national studies, aimed at adverse event (AE) identification, was performed. Previously identified AEs were screened for antithrombotic involvement. Crude and multi-level, case-mix adjusted ARAE and MRAE incidences were calculated. Various contextual ARAE characteristics were analysed. ARAE incidence between 2008 and 2016 decreased significantly in in-hospital deceased patients from 1.20% (95% confidence interval (CI): 0.63–2.27%) in 2008 to 0.54% (95% CI: 0.27–1.11%) in 2015/2016 (p = 0.02). In discharged patients ARAE incidence remained stable. By comparison, overall MRAE incidence remained stable for both deceased and discharged patients. Most ARAEs involved Vitamin-K antagonists (VKAs). Preventable ARAEs occurred more during weekends and with increasing multidisciplinary involvement. Antiplatelet and combined antithrombotic use seemed to be increasingly involved in ARAEs over time. ARAE incidence declined by 55% in deceased patients between 2008 and 2016. Opportunities for improving antithrombotic safety should target INR monitoring and care delivery aspects such as multidisciplinary involvement and weekend care. Future ARAE monitoring for the involvement of antiplatelet, combined antithrombotic and direct oral anticoagulant (DOAC) use is recommended.</jats:p> |
| doi_str_mv | 10.3390/jcm8060839 |
| facet_avail | Online, Free |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzM5MC9qY204MDYwODM5 |
| imprint | MDPI AG, 2019 |
| imprint_str_mv | MDPI AG, 2019 |
| institution | DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1 |
| issn | 2077-0383 |
| issn_str_mv | 2077-0383 |
| language | English |
| last_indexed | 2024-03-01T14:34:43.616Z |
| match_str | moesker2019occurrenceofantithromboticrelatedadverseeventsinhospitalizedpatientsincidenceandclinicalcontextbetween2008and2016 |
| mega_collection | MDPI AG (CrossRef) |
| physical | 839 |
| publishDate | 2019 |
| publishDateSort | 2019 |
| publisher | MDPI AG |
| record_format | ai |
| recordtype | ai |
| series | Journal of Clinical Medicine |
| source_id | 49 |
| spelling | Moesker, Marco J. Schutijser, Bernadette C.F.M. de Groot, Janke F. Langelaan, Maaike Spreeuwenberg, Peter Huisman, Menno V. de Bruijne, Martine C. Wagner, Cordula 2077-0383 MDPI AG General Medicine http://dx.doi.org/10.3390/jcm8060839 <jats:p>Antithrombotic drugs are consistently involved in medication-related adverse events (MRAEs) in hospitalized patients. We aimed to estimate the antithrombotic-related adverse event (ARAE) incidence between 2008 and 2016 and analyse their clinical context in hospitalized patients in The Netherlands. A post-hoc analysis of three national studies, aimed at adverse event (AE) identification, was performed. Previously identified AEs were screened for antithrombotic involvement. Crude and multi-level, case-mix adjusted ARAE and MRAE incidences were calculated. Various contextual ARAE characteristics were analysed. ARAE incidence between 2008 and 2016 decreased significantly in in-hospital deceased patients from 1.20% (95% confidence interval (CI): 0.63–2.27%) in 2008 to 0.54% (95% CI: 0.27–1.11%) in 2015/2016 (p = 0.02). In discharged patients ARAE incidence remained stable. By comparison, overall MRAE incidence remained stable for both deceased and discharged patients. Most ARAEs involved Vitamin-K antagonists (VKAs). Preventable ARAEs occurred more during weekends and with increasing multidisciplinary involvement. Antiplatelet and combined antithrombotic use seemed to be increasingly involved in ARAEs over time. ARAE incidence declined by 55% in deceased patients between 2008 and 2016. Opportunities for improving antithrombotic safety should target INR monitoring and care delivery aspects such as multidisciplinary involvement and weekend care. Future ARAE monitoring for the involvement of antiplatelet, combined antithrombotic and direct oral anticoagulant (DOAC) use is recommended.</jats:p> Occurrence of Antithrombotic Related Adverse Events in Hospitalized Patients: Incidence and Clinical Context between 2008 and 2016 Journal of Clinical Medicine |
| spellingShingle | Moesker, Marco J., Schutijser, Bernadette C.F.M., de Groot, Janke F., Langelaan, Maaike, Spreeuwenberg, Peter, Huisman, Menno V., de Bruijne, Martine C., Wagner, Cordula, Journal of Clinical Medicine, Occurrence of Antithrombotic Related Adverse Events in Hospitalized Patients: Incidence and Clinical Context between 2008 and 2016, General Medicine |
| title | Occurrence of Antithrombotic Related Adverse Events in Hospitalized Patients: Incidence and Clinical Context between 2008 and 2016 |
| title_full | Occurrence of Antithrombotic Related Adverse Events in Hospitalized Patients: Incidence and Clinical Context between 2008 and 2016 |
| title_fullStr | Occurrence of Antithrombotic Related Adverse Events in Hospitalized Patients: Incidence and Clinical Context between 2008 and 2016 |
| title_full_unstemmed | Occurrence of Antithrombotic Related Adverse Events in Hospitalized Patients: Incidence and Clinical Context between 2008 and 2016 |
| title_short | Occurrence of Antithrombotic Related Adverse Events in Hospitalized Patients: Incidence and Clinical Context between 2008 and 2016 |
| title_sort | occurrence of antithrombotic related adverse events in hospitalized patients: incidence and clinical context between 2008 and 2016 |
| title_unstemmed | Occurrence of Antithrombotic Related Adverse Events in Hospitalized Patients: Incidence and Clinical Context between 2008 and 2016 |
| topic | General Medicine |
| url | http://dx.doi.org/10.3390/jcm8060839 |